Clinical Trial Update: Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial assessed adding trastuzumab to chemotherapy after surgery in women with invasive breast cancer; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: HER2/Neu Positive, Progesterone Receptor Positive | Phase 3 | Status: COMPLETED | Results posted: 2020-09-23